Clinicopathologic Characteristics of Male Breast Cancer: A Report of 21 Cases in Radiotherapy Center of Hamedan, Iran

  • Published : 2013.12.31


Background: Male breast cancer accounts for less than 1% of all cancer in men and only around 1% of all diagnosed breast cancer. Despite a significant raise in the last 25 years, it still remains a rare disease. Materials and Methods: We conducted a retrospective study from 2004-2011 with 21 male breast cancer patients. We aimed to analyze the epidemiologic data (age, personal and family history), tumor characteristics (size, histological type, location, TNM stage, receptors), surgery, adjuvant chemotherapy and radiation therapy, hormonal therapy and survival (relapse, follow up, death) who reffered to our center with breast cancer. Results: The median age was $49.2{\pm}14.2$ years (range 30-83 years). A family history of breast cancer was noted in four cases. The main clinical complaint was a retroareolar mass in 85.7%of patients (n=18). Histologically, 85.7% (n=18)were invasive ductal carcinoma and 4.7% (n=1) had ductal carcinoma in situ and 9.4% (n=2) had mixed histology including invasive medullary and ductal carcinoma. Hormonal therapy was delivered to 16 cases (76.1%) due to ER or PR positivity. During median follow up of 30 months (3-84 month), distant metastases were evident in 4 cases (19%). During the follow-up period, only one patient died due to metastatic disease. The mean time to recurrence detection was 30 months. Conclusions: The percentage of cases of male breast cancer is very low compared to breast cancer in females, explaining why very few investigations have been conducted in Iran. Limited coverage in the literature make gender-specific findings difficult so future research of this entity involving multi-institutional cooperation and longer follow up is essential to provide new insights about the biological and clinical factors of this rare cancer.


  1. Bourthafour M, Belbarake R, Souadka A, et al (2011). Male breast cancer: a report of 127 cases at a Moroccan institution. BMC Res Notes, 4, 219.
  2. Cutuli B, Le-Nir CC, Serin D, et al (2010). Male breast cancer, Evolution of treatment and prognostic factors, Analysis of 489 cases. Crit Rev Oncol Hematol, 73, 246-54.
  3. Dauda AM, Misauno MA, Ojo EO (2011). Histopathological types of breast cancer in Gombe, north eastern Nigeria: a seven year review. Afr J Reprod Health Mar, 15, 109-11.
  4. Dnami S, Ozaki M, Mortiner J (2011). Male breast cancer: An update in diagnosis, treatment and molecular profiling. Maturites, 308-14.
  5. Gomez-Raposo C, Zaubrana Terar F, Mayganom S (2010). Male breast cancer. Cancer Treat Rev, 36, 451-7.
  6. Speirs V, Shaaban AM (2008). The rising incidence of breast cancer. Breast Cancer Res Treat, 115, 429-30.
  7. Tawil AN, Boulos FI, Chakhachiro Zl, et al (2011). Clinicopathologic and immunohistochemical characteristics of male breast cancer, A single center Experience, Breast J, 18, 65-8.
  8. Tallon-Aguilar L, Serrano-Borrero I, Lopez-Porras M (2011). Breast cancer in males. Cir Cir, 79, 296-8.
  9. Voney A, Kucuk A, Unsal M (2009). Male breast cancer: a retrospective analysis. Cancer Radiotherapie, 13, 103-7.
  10. Xia Q, Shi YX, Liu DG, Jiang WQ (2011). Clinicopathologic characteristic of male breast cancer: analysis of 25 cases at single institution. Fang Yi Ke Da Xue Xue Bao, 31, 1469-73.

Cited by

  1. Clinico-Morphological Profile and Receptor Status in Breast Cancer Patients in a South Indian Institution vol.15, pp.18, 2014,
  2. Male Breast Cancer: a 24 Year Experience of a Tertiary Care Hospital in Pakistan vol.16, pp.4, 2015,
  3. Male breast carcinoma: radiotherapy contributed to favorable local control in two cases and related literature review vol.20, pp.1, 2015,